文献速递白血病

CSF3R突变在急性髓系白血病中的亚型与功能类别依赖性预后影响:2500例队列研究

Subtype- and functional class-dependent prognostic impact of CSF3R mutations in acute myeloid leukaemia: A cohort study of 2500 patients.
PubMed 文献 · Br J Haematol · 2026-10-18

该研究分析2500例接受强化诱导治疗的新诊断非APL急性髓系白血病(AML)患者,CSF3R突变见于3.5%,常与CEBPA-bZIP突变和RUNX1::RUNX1T1融合共存。整体队列中CSF3R突变与较差无复发生存(RFS)相关,但与总生存(OS)或无事件生存(EFS)无关;预后影响呈分子背景与功能突变类别依赖性,在CEBPA-bZIP AML中不良关联最一致。

要点

  • CSF3R突变在非APL AML中占3.5%,常与CEBPA-bZIP突变和RUNX1::RUNX1T1融合共存。
  • 整体队列CSF3R突变仅与较差RFS相关,与OS和EFS无关。
  • CEBPA-bZIP AML中CSF3R突变与较差OS、EFS和RFS相关,多变量调整后持续存在。

核心结论

  • CSF3R突变在AML中的预后影响取决于分子背景和功能突变类别,在CEBPA-bZIP AML中不良关联最强。

研究设计与样本

  • 队列研究分析2500例新诊断de novo非APL AML患者,均接受强化诱导治疗。

主要发现

  • CSF3R突变见于3.5%的患者,常与CEBPA-bZIP突变和RUNX1::RUNX1T1融合共存。
  • 整体队列中CSF3R突变与较差RFS相关,但与OS或EFS无关。
  • CEBPA-bZIP AML中CSF3R突变与较差OS、EFS(HR 2.76;p=0.001)和RFS(HR 2.66;p=0.002)相关,多变量调整和移植时间依赖模型后持续存在。
  • 整体队列中膜近端激活突变(MPM)主要与较差RFS相关(HR 2.27;p=0.001),而胞质尾截短突变(CTTM)无一致不良影响。
  • CEBPA-bZIP AML中MPM和CTTM均显示不良EFS和RFS关联,但CTTM亚组较小。

临床怎么用

  • 在AML预后评估中应结合分子背景(尤其CEBPA-bZIP)和CSF3R突变功能类别解读其意义。

局限性

  • CTTM亚组样本量小,其预后关联需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Colony-stimulating factor 3 receptor (CSF3R) mutations occur in acute myeloid leukaemia (AML), but their prognostic significance remains unclear. We analysed 2500 patients with newly diagnosed de novo non-acute promyelocytic leukaemia (APL) AML treated with intensive induction therapy. CSF3Rmut were identified in 3.5% and frequently co-occurred with CCAAT/enhancer-binding protein alpha bZIP domain (CEBPA-bZip) mutations and RUNX family transcription factor 1::RUNX1 partner transcriptional co-repressor 1 (RUNX1::RUNX1T1) fusions. In the entire cohort, CSF3Rmut were associated with inferior relapse-free survival (RFS), but not overall survival (OS) or event-free survival (EFS). The prognostic impact was context-dependent. The adverse association was most consistent in CEBPA-bZip AML, with inferior OS, EFS (hazard ratio [HR], 2.76; p = 0.001) and RFS (HR, 2.66; p = 0.002) and persisted after multivariable adjustment and time-dependent modelling of transplantation. Membrane-proximal activating mutations (MPM) were associated primarily with inferior RFS (HR, 2.27; p = 0.001) in the overall cohort, whereas cytoplasmic-tail truncating mutations (CTTM) showed no consistent adverse effect. In CEBPA-bZip AML, both MPM and CTTM showed adverse EFS and RFS associations, although the CTTM subgroup was small. The prognostic impact of CSF3Rmut in AML depends on molecular context and functional mutation class, with the strongest adverse associations observed in CEBPA-bZip AML.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. An J, Hui Y, Li Y, et al. Subtype- and functional class-dependent prognostic impact of CSF3R mutations in acute myeloid leukaemia: A cohort study of 2500 patients. Br J Haematol. 2026. PMID: 42893900. doi:10.1111/bjh.70909

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。